Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 12896
TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738166(US20250145576, Compound K13)
Affinity DataIC50: 10nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738168(US20250145576, Compound K15)
Affinity DataIC50: 10nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM50607441(CHEMBL5220960 | US20250145576, Compound K1)
Affinity DataIC50: 55nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738195(US20250145576, Compound K22)
Affinity DataIC50: 55nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738194(US20250145576, Compound K21)
Affinity DataIC50: 55nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738177(US20250145576, Compound K20)
Affinity DataIC50: 55nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738172(US20250145576, Compound K19)
Affinity DataIC50: 55nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738171(US20250145576, Compound K18)
Affinity DataIC50: 55nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738165(US20250145576, Compound K10)
Affinity DataIC50: 300nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738164(US20250145576, Compound K7)
Affinity DataIC50: 300nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738161(US20250145576, Compound K6)
Affinity DataIC50: 300nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM50607442(CHEMBL5219348 | US20250145576, Compound K2)
Affinity DataIC50: 300nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738170(US20250145576, Compound K17)
Affinity DataIC50: 300nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent

TargetCathepsin K(Human)
Shandong New Time Pharmaceutical

US Patent
LigandPNGBDBM738169(US20250145576, Compound K16)
Affinity DataIC50: 300nMAssay Description:Cathepsin K (CTSK, EC 3.4.22.38) is a lysosomal cysteine protease, participates in osteoclastic bone remodeling and resorption, and can further degra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
US Patent